Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,016 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ventricular Sigmoid Septum as a Risk Factor for Anthracycline-Induced Cancer Therapeutics-Related Cardiac Dysfunction in Patients With Malignant Lymphoma.
Nakayama T, Oshima Y, Shintani Y, Yamamoto J, Yokoi M, Ito T, Wakami K, Kitada S, Goto T, Hashimoto H, Kusumoto S, Sugiura T, Iida S, Seo Y. Nakayama T, et al. Among authors: hashimoto h. Circ Rep. 2022 Mar 26;4(4):173-182. doi: 10.1253/circrep.CR-21-0145. eCollection 2022 Apr 8. Circ Rep. 2022. PMID: 35434414 Free PMC article.
Humoral and cellular immune response to second and third severe acute respiratory syndrome coronavirus 2 mRNA vaccine in patients with plasma cell dyscrasia.
Suzuki T, Kusumoto S, Kamezaki Y, Hashimoto H, Nishitarumizu N, Nakanishi Y, Kato Y, Kawai A, Matsunaga N, Ebina T, Nakamura T, Marumo Y, Oiwa K, Kinoshita S, Narita T, Ito A, Inagaki A, Ri M, Komatsu H, Aritsu T, Iida S. Suzuki T, et al. Among authors: hashimoto h. Cancer Med. 2023 Jun;12(12):13135-13144. doi: 10.1002/cam4.5996. Epub 2023 Apr 26. Cancer Med. 2023. PMID: 37102222 Free PMC article.
Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study.
Onozawa M, Kusumoto S, Najima Y, Hashimoto H, Okada K, Tamaki M, Tanaka M, Sato T, Takahashi T, Hatano K, Onodera K, Moriuchi Y, Yakushijin K, Kanda J, Nagafuji K, Ogata M, Nakano N, Tamori A, Mizokami M. Onozawa M, et al. Among authors: hashimoto h. Transplant Cell Ther. 2024 Mar;30(3):330.e1-330.e8. doi: 10.1016/j.jtct.2024.01.059. Epub 2024 Jan 17. Transplant Cell Ther. 2024. PMID: 38242442
A Multicenter, Open-label, Clinical Trial to Assess the Effectiveness and Safety of Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-intensity Conditioning in Relapsed/refractory Anaplastic Large-cell Lymphoma in Children.
Kada A, Fukano R, Mori T, Kamei M, Tanaka F, Ueyama J, Sekimizu M, Osumi T, Mori T, Koga Y, Ohki K, Fujita N, Mitsui T, Saito AM, Hashimoto H, Kobayashi R. Kada A, et al. Among authors: hashimoto h. Acta Med Okayama. 2020 Feb;74(1):89-94. doi: 10.18926/AMO/57959. Acta Med Okayama. 2020. PMID: 32099255 Free article.
Efficacy and safety of administering pediatric treatment to adolescent patients with mature B-cell non-Hodgkin lymphoma within the Japanese Pediatric Leukemia/Lymphoma Study Group clinical trial.
Sekimizu M, Hashimoto H, Mori T, Kobayashi R, Horibe K, Tsurusawa M. Sekimizu M, et al. Among authors: hashimoto h. Pediatr Blood Cancer. 2018 Aug;65(8):e27068. doi: 10.1002/pbc.27068. Epub 2018 Apr 10. Pediatr Blood Cancer. 2018. PMID: 29637700 Clinical Trial.
4,016 results